Alkermes Inc. plc

ALKSNASDAQUSD
55.08 USD
2.25 (4.26%)AT CLOSE (11:59 AM EDT)
54.57
0.52 (0.94%)
POST MARKET (AS OF 07:01 PM EDT)
Post Market
AS OF 07:01 PM EDT
54.57
0.52 (0.94%)
🔴Market: CLOSED

ALKS is currently priced at $55.08. ALKS shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, ALKS trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 26, 2026.

Open?$52.87
High?$55.28
Low?$52.39
Prev. Close?$52.83
Volume?7.6M
Avg. Volume?2.5M
VWAP?$54.49
Rel. Volume?3.07x
Bid / Ask
Bid?$46.80 × 100
Ask?$62.67 × 100
Spread?$15.87
Midpoint?$54.74
Valuation & Ratios
Market Cap?9.2B
Shares Out?166.7M
Float?162.4M
Float %?98.4%
P/E Ratio?60.11
P/B Ratio?5.24
EPS?$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Employees
2.0K
Market Cap
8.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1991-07-16
Address
CONNAUGHT HOUSE
DUBLIN 4, L2 00000
Phone: 00-353-1-772-8000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
60
Momentum?
13
Short Sent.?
34
Piotroski F-Score?3/9Weak
Altman Z-Score?2.66Grey
Confidence?68%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.06%High
Short Interest?18.0M
Days to Cover?9.5
Free Float162.4M
Avg Daily Volume1.9M
Settlement Date2026-06-15
Financial Health
Current Ratio?2.27Strong
Quick Ratio?1.70Adequate
Cash Ratio?0.59Adequate
Debt/Equity?0.86Moderate
ValuationRICHLY VALUEDvs 4 peers + S&P 500
Score
44/100
P/E?
Peers
50
S&P
9
60.1PRICEY
P/B?
Peers
40
S&P
35
5.24FAIR
P/S?
Peers
40
S&P
23
5.88FAIR
P/FCF?
Peers
25
S&P
16
41.4PRICEY
EV/EBITDA?
Peers
25
S&P
3
44.8HIGH
EV/Sales?
Peers
40
S&P
23
6.62HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
29
8.7%FAIR
ROA?
Peers
50
S&P
33
3.6%FAIR
Cash Flow & Enterprise
FCF?$221.8M
Enterprise Value?$10.3B
Fundamentals ratios updated end of day